Health Invest Partners Ab Merus N.V. Transaction History
Health Invest Partners Ab
- $221 Million
- Q2 2025
A detailed history of Health Invest Partners Ab transactions in Merus N.V. stock. As of the latest transaction made, Health Invest Partners Ab holds 59,889 shares of MRUS stock, worth $4.08 Million. This represents 1.42% of its overall portfolio holdings.
Number of Shares
59,889
Previous 35,292
69.7%
Holding current value
$4.08 Million
Previous $1.49 Million
112.12%
% of portfolio
1.42%
Previous 0.69%
Shares
7 transactions
Others Institutions Holding MRUS
# of Institutions
217Shares Held
65.3MCall Options Held
311KPut Options Held
556K-
Paradigm Biocapital Advisors LP New York, NY4.28MShares$292 Million10.51% of portfolio
-
Rtw Investments, LP New York, NY4MShares$272 Million3.23% of portfolio
-
Wellington Management Group LLP Boston, MA3.73MShares$254 Million0.04% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$240 Million17.29% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$230 Million4.09% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $3.12B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...